Surgical Versus Medical Treatment of Acromegaly

December 2, 2015 updated by: University of Aarhus

Surgical Versus Medical Treatment of Acromegaly: Effects on Biochemical Markers

Evaluate biochemical differences in acromegalic patients treated with surgery versus somatostatin analogues (SMS) (after surgery or alone).

Hypothesis: Treatment modality exhibit different biochemical responses in acromegaly.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

63

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Denmark
      • Århus, Denmark, 8000
        • Århus University Hospital, Medical department M

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Acromegalic patients followed in the outpatient clinic at Århus University Hospital, Medical Department M

Description

Inclusion Criteria:

  • Acromegaly diagnosis
  • treated with Somatostatin analogues or surgery
  • in treatment control

Exclusion Criteria:

  • treatment with GH-antagonist
  • never treated
  • not in treatment control

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Acromegaly patients, somatostain analogues
Acromegaly patients, surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Aarhus

Investigators

  • Study Director: Kristine Z Rubeck, stud. med., Medical department M, Århus University Hospital
  • Principal Investigator: Jens Otto L Jørgensen, MD, Medical department M, Århus University Hospital
  • Study Director: Michael Madsen, MD, Medical department M, Århus University Hospital
  • Study Director: Sanne Fisker, MD, Medical department M, Århus University Hospital
  • Study Director: Caroline Adreasen, MD, Medical department M, Århus University Hospital
  • Study Director: Jan Frystyk, MD, Medical department M, Århus University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2009

Primary Completion (Actual)

February 1, 2010

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

October 21, 2009

First Submitted That Met QC Criteria

October 21, 2009

First Posted (Estimate)

October 22, 2009

Study Record Updates

Last Update Posted (Estimate)

December 3, 2015

Last Update Submitted That Met QC Criteria

December 2, 2015

Last Verified

June 1, 2011

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • kzr200809

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acromegaly

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe